Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced it has entered into a definitive agreement to be …
NASDAQ
Dig out the deckchairs, stock up on strawberries and put the bubbly on …
Royal Opera
ARIAD Pharmaceuticals, Inc. ARIA remains focused on the discovery, development and commercialization of breakthrough treatments for cancer. This year was a tough one for the pharma sector, which had to grapple …
Strong
Ariad stock rocketed nearly 73% on Jan. 9 when the company announced it had reached an agreement to be acquired, an announcement timed to coincide with the JPMorgan Healthcare Conference in San Francisco, …
Royal Bank of Canada
If you’re looking for a way to significantly change the experience with the stock Music app, then you need to check out Aria, a new jailbreak tweak recently released on Cydia. Aria is a $1.99 release that’s available on …
for each share of ARIAD stock. Following the purchase of shares in the tender offer, ARIAD will become an …
Business Wire
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock closed up 3.18% Wednesday evening on rumors that the US-based oncology company is being targeted by AstraZeneca plc (ADR) (NYSE:AZN) and Shire plc (ADR) …
Of all the easy choices, Senators Sanders and Representative Cummings have now decided to go after biotechnology company, Ariad Pharmaceuticals (NASDAQ ... pulling the product from the market. Ariad's …
Seeking Alpha
Moving forward, I've got incredibly high hopes for Ariad Pharmaceuticals stock. As seen in the data that was provided yesterday, the company continues to innovate and find ways to make the quality of life for those …
Ariad's stock was on a roll in 2016, rising 99.04 percent. For 2017, the stock has already surged around 90 percent, after accounting for Monday's gains.
CNBC3mon